Crime, Drugs & Public Order
Overdose Deaths
The decline is real — and naloxone access plus supply pressure drove it, not permissiveness.
The Stakes
For a decade the line on the chart only went up, and every point was someone's son or daughter. Then, for the first time in years, it bent down — and that's worth saying out loud, because hope is fuel. But the decline didn't come from looking away. It came from naloxone in more hands, record seizures squeezing supply, and pressure on the cartels and precursor chemicals that feed the pills. Understanding what actually drove the drop matters, because the wrong lesson — that permissiveness worked — would throw away the progress.
The Receipts
Every figure cites a primary federal source. Tap a chip to check it yourself.
~27% dropCDC provisional data estimate about 80,000 overdose deaths in 2024, down roughly 27% from about 110,000 in 2023 — the largest single-year decline on record and the lowest total since 2019.
CDC NCHS ↗~24% / 12 moAn earlier CDC milestone showed a roughly 24% decline in the 12 months ending September 2024 versus the prior year — the same downward trend measured over a rolling window.
CDC ↗Opioids led the dropOverdose deaths involving opioids fell from roughly 83,000 in 2023 to about 55,000 in 2024 — the bulk of the overall decline came from the fentanyl-driven category.
CDC ↗Naloxone OTCThe FDA approved over-the-counter naloxone (Narcan) in 2023, dramatically widening access to the reversal drug as deaths began falling — a harm-reduction win conservatives should credit.
FDA ↗Record seizures alongsideThe decline coincided with record fentanyl and counterfeit-pill seizures and precursor-chemical pressure — supply-side enforcement moving in the same direction as expanded naloxone.
DEA ↗Their Best Argument — and Why It Fails
The steelman
The decline proves harm reduction works and the drug war doesn't. Naloxone, fentanyl test strips, and treatment access — not enforcement — saved these lives, and the lesson is to double down on public-health measures and stop criminalizing users.
The rebuttal
Harm reduction deserves real credit, and conservatives should say so plainly: over-the-counter naloxone put the reversal drug in countless hands, and lives were saved. But the same period brought record seizures and precursor pressure on the supply, so the honest reading is that both moved together — demand-side care and supply-side enforcement, not one instead of the other. Fentanyl is uniquely interdictable because it's manufactured, not grown, so squeezing supply genuinely bends the curve. The wrong lesson would be that permissiveness drove the drop; the open-air-tolerance experiments that didn't pair care with consequence saw deaths keep climbing until they reversed. Keep the naloxone. Keep the pressure. That's what worked.
The Conservative Fix
- 1
Sustain naloxone saturation — schools, libraries, first responders, public buildings — as a permanent baseline.
State / Local - 2
Maintain supply-side pressure: port-of-entry scanning, precursor sanctions, cartel-finance enforcement.
Federal - 3
Fund treatment-on-demand and medication-assisted treatment so reversed overdoses become recoveries.
State - 4
Keep publishing provisional overdose data fast, so policy can track what's actually working.
Federal
Answer the Muster
Who decides this: Your U.S. House member and Senators for supply-side and data policy; state and local officials for naloxone and treatment
I'm a constituent in [district]. Overdose deaths finally fell — driven by naloxone access AND supply pressure together. I'm asking [official] to keep both: naloxone everywhere and hard enforcement on supply. Where does [he/she] stand?